Position in ANL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,717,883
+$4,694,656 QoQ
Shares Held
681,775
+5799.7% QoQ
Ownership
1.06%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,570,822,033 across 342 Biotechnology names. ANL ranks #178 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in ANL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,717,883 | 681,775 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $23,227 | 11,556 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $44,519 | 16,581 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $37,417 | 18,850 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $60,792 | 18,648 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $177,801 | 20,025 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $203,120 | 22,594 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $450,000 | 30,000 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||